Safety of Ceasing Aspirin Used Without a Clinical Indication After Age 70 Years: A Subgroup Analysis of the ASPREE Randomized Trial

Ann Intern Med. 2022 May;175(5):761-764. doi: 10.7326/M21-3823. Epub 2022 Mar 15.
No abstract available

Publication types

  • Randomized Controlled Trial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aspirin* / adverse effects
  • Cardiovascular Diseases*
  • Double-Blind Method
  • Humans
  • Platelet Aggregation Inhibitors / adverse effects

Substances

  • Platelet Aggregation Inhibitors
  • Aspirin